Browsing Tag
BARDA
7 posts
Sanofi taps Novavax’s Matrix-M for flu: Is NVAX stock finally turning a corner?
Novavax (NASDAQ: NVAX) expands Sanofi partnership, granting rights to Matrix-M adjuvant for pandemic flu candidates. See stock impact and outlook.
Lumos Diagnostics (ASX: LDX) reaches 500-patient milestone in FebriDx CLIA study
Lumos Diagnostics hits a key 500-patient milestone in its FebriDx CLIA waiver study, triggering BARDA funds. FDA application expected by October 2025.
HHS invests $590m in Moderna for mRNA-based pandemic influenza vaccines
The U.S. Department of Health and Human Services (HHS) has announced a monumental $590 million investment in Moderna,…
Cue Health awarded $28m BARDA contract for multiplex test for Flu, RSV, and COVID-19
Healthcare technology company Cue Health (Nasdaq: HLTH) announced that it has been awarded a contract worth approximately $28…
Microbiome company Vedanta Biosciences raises $68m in Series D
Vedanta Biosciences, a clinical-stage microbiome company founded by PureTech Health, has raised $68 million in a Series D…
Cipla Therapeutics partners with SIGA Technologies for antibacterial drugs
Cipla Therapeutics, an Indian pharma company, and SIGA Technologies have entered into a partnership to provide sustained innovation…
Moderna bags $1.5bn contract to supply mRNA-1273 Covid-19 vaccine to US govt
Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million…